Skip to main content

Servier launches U.S. cancer business with plans to double headcount in next 5 years

France’s second-largest pharmaceutical company, Servier Group, opened its first U.S.-based commercial subsidiary in Boston this week, with plans to double the business over the next five years.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.